CPN1 and metabolic disease: Previously, we and other groups have demonstrated that Cpn is effective to ameliorate metabolic disorders, such as decreasing blood lipids, improving insulin resistance and alleviating chronic inflammation [15, 16, 22], which marks Cpn as a potential therapeutic agent for atherosclerosis.